#United States #New York #M&A Class Action #Supernus Pharmaceuticals #Indivior Pharmaceuticals

Investigation into Supernus Pharmaceuticals

On August 3, 2026, Monteverde & Associates PC, known for its class action securities work, announced an investigation into Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN). This inquiry comes in the wake of Supernus's proposed sale to Indivior Pharmaceuticals, Inc., raising significant questions for shareholders regarding the terms of the deal.

Class action attorney Juan Monteverde, who leads the firm, has successfully recovered millions for shareholders in the past and has built a reputation as one of the top firms in the industry, as highlighted in the 2025 ISS Securities Class Action Services Report. The firm's headquarters in New York's iconic Empire State Building adds to its credibility in handling complex class action cases.

The Sale of Supernus Pharmaceuticals

The key aspect of this investigation revolves around the proposed transaction where Supernus shareholders are slated to receive 1.5401 common shares of Indivior for every share they own in Supernus. Shareholders are expressing concerns about whether this exchange represents a fair deal and if the proposed terms adequately reflect the true value of their investments.

Monteverde emphasizes the importance of shareholders knowing their rights and understanding the details surrounding such transactions. He invites shareholders to voice their concerns and to seek clarity on the fairness of the deal. The firm operates on the belief that no one is above the law and aims to ensure transparency in such high-stakes situations.

Importance of Due Process

The M&A Class Action Firm is committed to representing shareholders through the legal process, emphasizing that having a reputable attorney can make a significant difference in outcomes. Potential clients are encouraged to discuss their individual circumstances and confront questions such as:

• - Does your firm engage in class action litigation?
• - What is your track record for recovering funds for shareholders?
• - Can you share your past case outcomes?

As these inquiries go forward, potential claimants are reminded that the firm offers free consultations, meaning there is no cost or obligation to seek information about their rights. Experience in navigating securities law is vital for understanding potential legal avenues.

About Monteverde & Associates PC

Monteverde & Associates PC specializes in class action and securities litigation with a strong footing in trial and appellate courts, including the U.S. Supreme Court. They take pride in their history of holding corporations accountable and advocating for shareholder rights. Their work reflects a commitment to justice, making them a reliable choice for those facing similar challenges.

For those whose investments could be impacted by the transaction between Supernus and Indivior, access to legal resources and expertise became more crucial than ever. To gain insights or to connect with Juan Monteverde, shareholders can visit the firm’s website or reach out directly via email or phone.

Conclusion

As the investigation unfolds, the outcome could have implications not only on the immediate future of Supernus Pharmaceuticals but also on how shareholders perceive and engage with corporate transactions. Being informed and prepared is essential for stakeholders navigating these complexities in the financial landscape. The opportunity for shareholders to engage with Monteverde & Associates is a proactive step toward ensuring that their rights are safeguarded and that fair practices are adhered to in all corporate dealings.